(Q56444295)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

Rosamonde Elizabeth Banks

17 January 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Noel Clarke

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Eamonn R Maher

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

M R Morris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

C J Ricketts

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

D Gentle

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

F McRonald

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

N Carli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

H Khalili

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

T Kishida

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

M Yao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

F Latif

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

language of work or name

English

0 references

publication date

6 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1390-1401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21132003%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2010.525

17 January 2020

exact match

0 references

cites work

Making sense of latent TGFbeta activation

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Fibrillin-1 regulates the bioavailability of TGFbeta1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Aberrant methylation of FBN2 in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Recent advances in the treatment of renal cell carcinoma and the role of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Promoter hypermethylation profile of kidney cancer with new proapoptotic p53 target genes and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Sequences of members of the human gene family for the c subunit of mitochondrial ATP synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Identification of a mammalian glutaminyl cyclase converting glutaminyl into pyroglutamyl peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Cloning, mapping, and expression analysis of a gene encoding a novel mammalian EGF-related protein (SCUBE1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Regulation of oxidative phosphorylation, the mitochondrial membrane potential, and their role in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Identification of novel target genes by an epigenetic reactivation screen of renal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Frequent silencing of the candidate tumor suppressor PCDH20 by epigenetic mechanism in non-small-cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Identification of the von Hippel-Lindau disease tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

The role of chromatin during transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Functional epigenomics identifies genes frequently silenced in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Epigenetic silencing of novel tumor suppressors in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Endothelin-1 promotes cell survival in renal cell carcinoma through the ET(A) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Primary structure and functional expression of a glutaminyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Germline SDHB mutations and familial renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

The role of mammalian coronins in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

The molecular genetics of Marfan syndrome and related microfibrillopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Three DNA methylation epigenotypes in human colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

PCDH8, the human homolog of PAPC, is a candidate tumor suppressor of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Estimates of cancer incidence and mortality in Europe in 1995

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525

Identification of potential gene markers and insights into the pathophysiology of pheochromocytoma malignancy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.525